Cochrane is delighted to announce the signing of a new contract with John Wiley & Sons, Ltd. to publish the Cochrane Library for the next 10 years from January 2021. The agreement guarantees major investment into future development of the Library to sustain Cochrane as the world’s pre-eminent collection of high-quality evidence to inform…
Eve Tomlinson, NIHR Network Support Fellow for the Cochrane Cancer Network presents the work completed across the cancer network to complete an exercise in stakeholder mapping.
The Cochrane Cancer Network supports the work of six Cochrane Review Groups (CRGs): Breast Cancer, Childhood Cancer, Gynaecological, Neuro-oncology and Orphan Cancers,…
Following the success of the inaugural Global Evidence Summit in Cape Town in 2017, we are delighted to welcome you on behalf of the Czech National Centre for Evidence-Based Healthcare and Knowledge Translation and Masaryk University, to the 2021 Global Evidence Summit in Prague.
We hope you will join us from 5-8 October 2021 at the O2 universum…
A Message from the Governing Board Co-chairs, Chief Executive Officer and Editor in Chief
We are delighted to publish Cochrane’s 2019 Annual Review, entitled: ‘Embracing Diversity’. As we celebrate 12 months of achievements and reflect on the global expansion and increasing impact of Cochrane’s work, and the growing diversity of our…
Cochrane has introduced a new Research Integrity team in the Editorial & Methods Department. The team comprises four members and represents a significantly increased investment in promoting Research Integrity in Cochrane.
The Research Integrity Editor, Stephanie Boughton
The Senior Research Integrity Editor, Lisa Bero
The EMD Senior…
Anne Littlewood (Cochrane Information Specialists’ Executive), Robin Featherstone (Information Specialist, Cochrane Editorial and Methods Department)
The purpose of the Cochrane Information Specialists’ Executive (CIS Exec) is to provide advice on policy and issues related to the role of the Cochrane Information Specialist. To that end, the CIS…
The Governing Board is pleased to announce the appointment of Tracey Howe as Co-Chair and Karen Kelly as a new member
Governing Board Co-Chair: Tracey Howe
Cochrane’s Governing Board has appointed Professor Tracey Howe as its new Co-Chair from 1st September 2020. She will work alongside fellow Co-Chair Catherine Marshall, and replace…
RevMan Web is Cochrane’s online review-writing platform. It is available for use by all authors and editors of Cochrane Reviews of interventions. One benefit of RevMan Web is that it is constantly being updated with new features for making writing systematic reviews easier and more efficient.
This collection explores different features in…
RevMan Web is Cochrane’s online review-writing platform. It is available for use by all authors and editors of Cochrane Reviews of interventions. One benefit of RevMan Web is that it is constantly being updated with new features for making writing systematic reviews easier and more efficient.
Conducting sensitivity analysis is a key part of…
Dear Cochrane Colloquium colleagues and friends,
It is with the deepest disappointment and regret that I have to inform you that as a result of the continued spread and impact of the COVID-19 (coronavirus) across the world, Cochrane’s 27th Colloquium in Toronto, Canada, between 4-7th October this year has been cancelled. …
The agenda and open access papers for the Cochrane Governing Board teleconference on April 29th are now available to view online, for information only.
Cochrane's governing body is the Governing Board. The Board is responsible for overseeing the development and implementation of Cochrane’s strategic direction. If you would like to comment…
Cochrane Library Editor in Chief and Deputy Editor in Chief, Karla Soares-Weiser and Toby Lasserson, presented to a large group of international journalists as part of the Wiley Science Talks webinar series on April 27. This webinar series, supported by the World Federation of Science Journalists and the Association of Health Care Journalists,…
Are you interested in helping to shape Cochrane evidence related to COVID-19, and to help make it accessible to the public? We are forming a group of patients and carers who are able to take on tasks at short notice to help contribute to Cochrane’s rapid review work, and more.
Cochrane responds to the COVID-19
As part of our response to the…
The NIHR Complex Reviews Unit (CRSU) has offered to provide advice and analytical support for COVID-19 related evidence synthesis, in whatever way Cochrane authors consider appropriate, including support for Rapid Reviews and Living Systematic Reviews.
Expertise within the CRSU include:
Diagnostic test accuracy reviews
Network meta-…
Cochrane has launched a new online learning module on Synthesis Without Meta-analysis (SWiM) reporting guidelines. Designed for systematic review authors or readers, the module provides training on the nine SWiM items to improve the transparent reporting of synthesis of intervention effects when the synthesis does not use meta-analysis of…
The revised policy, which we plan to implement on October 14, 2020, includes stricter rules for financial interests and the consideration of non-financial interests.
Cochrane is proud to release its revised Conflict of Interest policy for Cochrane Library Content. The policy was created with the support of a project board made up of key…
The agenda and open access papers for the Cochrane Governing Board teleconference on 30-31 March and 1st of April are now available to view online, for information only.
Cochrane's governing body is the Governing Board. The Board is responsible for overseeing the development and implementation of Cochrane’s strategic direction. If you would…
The nomination period for a new Co-Chair of the Governing Board is still open until Tuesday 14th April 2020 in any timezone. If you hold, or have held, some kind of leadership position in Cochrane you are invited to apply.
The Board has two Co-Chairs, to share workload, utilize complementary skills and experience, and permit continuity through…
RevMan Web is Cochrane’s online review-writing platform. It is available for use by all authors and editors of Cochrane Reviews of interventions. One benefit of RevMan Web is that it is constantly being updated with new features for making writing systematic reviews easier and more efficient.
The Validation Report in RevMan Web helps…
FURTHER EXTENSION: The deadline for abstract submissions is now 23.59 UTC, 6 April 2020
Dear Community Colleagues,
As a result of the continued spread and impact of the COVID-19 (coronavirus) across the world, we wanted to update you with important news and information regarding Cochrane’s 27th annual Colloquium in Toronto, 4-7th…
Cochrane is delighted to announce the signing of a new contract with John Wiley & Sons, Ltd. to publish the Cochrane Library for the next 10 years from January 2021. The agreement guarantees major investment into future development of the Library to sustain Cochrane as the world’s pre-eminent collection of high-quality evidence to inform…
Eve Tomlinson, NIHR Network Support Fellow for the Cochrane Cancer Network presents the work completed across the cancer network to complete an exercise in stakeholder mapping. The Cochrane Cancer Network supports the work of six Cochrane Review Groups (CRGs): Breast Cancer, Childhood Cancer, Gynaecological, Neuro-oncology and Orphan Cancers,…
Following the success of the inaugural Global Evidence Summit in Cape Town in 2017, we are delighted to welcome you on behalf of the Czech National Centre for Evidence-Based Healthcare and Knowledge Translation and Masaryk University, to the 2021 Global Evidence Summit in Prague. We hope you will join us from 5-8 October 2021 at the O2 universum…
A Message from the Governing Board Co-chairs, Chief Executive Officer and Editor in Chief We are delighted to publish Cochrane’s 2019 Annual Review, entitled: ‘Embracing Diversity’. As we celebrate 12 months of achievements and reflect on the global expansion and increasing impact of Cochrane’s work, and the growing diversity of our…
Cochrane has introduced a new Research Integrity team in the Editorial & Methods Department. The team comprises four members and represents a significantly increased investment in promoting Research Integrity in Cochrane. The Research Integrity Editor, Stephanie Boughton The Senior Research Integrity Editor, Lisa Bero The EMD Senior…
Anne Littlewood (Cochrane Information Specialists’ Executive), Robin Featherstone (Information Specialist, Cochrane Editorial and Methods Department) The purpose of the Cochrane Information Specialists’ Executive (CIS Exec) is to provide advice on policy and issues related to the role of the Cochrane Information Specialist. To that end, the CIS…
The Governing Board is pleased to announce the appointment of Tracey Howe as Co-Chair and Karen Kelly as a new member Governing Board Co-Chair: Tracey Howe Cochrane’s Governing Board has appointed Professor Tracey Howe as its new Co-Chair from 1st September 2020. She will work alongside fellow Co-Chair Catherine Marshall, and replace…
RevMan Web is Cochrane’s online review-writing platform. It is available for use by all authors and editors of Cochrane Reviews of interventions. One benefit of RevMan Web is that it is constantly being updated with new features for making writing systematic reviews easier and more efficient. This collection explores different features in…
RevMan Web is Cochrane’s online review-writing platform. It is available for use by all authors and editors of Cochrane Reviews of interventions. One benefit of RevMan Web is that it is constantly being updated with new features for making writing systematic reviews easier and more efficient. Conducting sensitivity analysis is a key part of…
Dear Cochrane Colloquium colleagues and friends, It is with the deepest disappointment and regret that I have to inform you that as a result of the continued spread and impact of the COVID-19 (coronavirus) across the world, Cochrane’s 27th Colloquium in Toronto, Canada, between 4-7th October this year has been cancelled. …
The agenda and open access papers for the Cochrane Governing Board teleconference on April 29th are now available to view online, for information only. Cochrane's governing body is the Governing Board. The Board is responsible for overseeing the development and implementation of Cochrane’s strategic direction. If you would like to comment…
Cochrane Library Editor in Chief and Deputy Editor in Chief, Karla Soares-Weiser and Toby Lasserson, presented to a large group of international journalists as part of the Wiley Science Talks webinar series on April 27. This webinar series, supported by the World Federation of Science Journalists and the Association of Health Care Journalists,…
Are you interested in helping to shape Cochrane evidence related to COVID-19, and to help make it accessible to the public? We are forming a group of patients and carers who are able to take on tasks at short notice to help contribute to Cochrane’s rapid review work, and more. Cochrane responds to the COVID-19 As part of our response to the…
The NIHR Complex Reviews Unit (CRSU) has offered to provide advice and analytical support for COVID-19 related evidence synthesis, in whatever way Cochrane authors consider appropriate, including support for Rapid Reviews and Living Systematic Reviews. Expertise within the CRSU include: Diagnostic test accuracy reviews Network meta-…
Cochrane has launched a new online learning module on Synthesis Without Meta-analysis (SWiM) reporting guidelines. Designed for systematic review authors or readers, the module provides training on the nine SWiM items to improve the transparent reporting of synthesis of intervention effects when the synthesis does not use meta-analysis of…
The revised policy, which we plan to implement on October 14, 2020, includes stricter rules for financial interests and the consideration of non-financial interests. Cochrane is proud to release its revised Conflict of Interest policy for Cochrane Library Content. The policy was created with the support of a project board made up of key…
The agenda and open access papers for the Cochrane Governing Board teleconference on 30-31 March and 1st of April are now available to view online, for information only. Cochrane's governing body is the Governing Board. The Board is responsible for overseeing the development and implementation of Cochrane’s strategic direction. If you would…
The nomination period for a new Co-Chair of the Governing Board is still open until Tuesday 14th April 2020 in any timezone. If you hold, or have held, some kind of leadership position in Cochrane you are invited to apply. The Board has two Co-Chairs, to share workload, utilize complementary skills and experience, and permit continuity through…
RevMan Web is Cochrane’s online review-writing platform. It is available for use by all authors and editors of Cochrane Reviews of interventions. One benefit of RevMan Web is that it is constantly being updated with new features for making writing systematic reviews easier and more efficient. The Validation Report in RevMan Web helps…
FURTHER EXTENSION: The deadline for abstract submissions is now 23.59 UTC, 6 April 2020 Dear Community Colleagues, As a result of the continued spread and impact of the COVID-19 (coronavirus) across the world, we wanted to update you with important news and information regarding Cochrane’s 27th annual Colloquium in Toronto, 4-7th…